Stuart M. Sprague
Expertise in
36
conditions

Dr. Stuart M. Sprague

Nephrology | Transplant Surgery
1000 Central St., Suite 800, 
Evanston, IL 
Accepting New Patients
Offers Telehealth
44 Years of Experience
Referral may be required
Before you request
Expertise in
36
conditions
1000 Central St., Suite 800, 
Evanston, IL 

Overview

Stuart Sprague, DO, a nephrologist at Endeavor Health, brings decades of clinical experience and research to the care of patients with kidney disease. His work spans rare diseases, mineral metabolism and complex diagnostic challenges. Dr. Sprague is known for a patient-centered approach, especially for those who don’t fit typical treatment algorithms, and he continues to explore innovations in dialysis and artificial kidney development.

Dr. Sprague is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Chronic Kidney Disease, Hypercalcemia, Milk-Alkali Syndrome, Parathyroidectomy, and Kidney Transplant.

Dr. Sprague is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 86 peer reviewed articles and participating in 8 clinical trials. Dr. Sprague is currently accepting new patients.

Graduate Year

1982

Specialties

Nephrology
Transplant Surgery

Licenses

Internal Medicine in IL

Board Certifications

American Board Of Internal Medicine

Fellowships

University of Chicago, Nephrology, 1989

Hospital Affiliations

Northwestern Memorial Hospital
Swedish Hospital
Northshore University Healthsystem - Evanston Hospital

Languages Spoken

English
Hebrew
Yiddish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Celtic
  • HMO
  • INSURANCE PLAN
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Endeavor Health Medical Group
1000 Central St., Suite 800, Evanston, IL 60201
Other Locations
Endeavor Health Medical Group
2150 Pfingsten Rd., Suite 3000, Glenview, IL 60026

Additional Areas of Focus

Dr. Sprague has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
Enrollment Status: Completed
Publish Date: July 14, 2026
Intervention Type: Other
A Phase 1b, Multicenter, Open-Label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Mezagitamab (TAK-079) in Patients With Primary IgA Nephropathy in Combination With Stable Background Therapy
A Phase 1b, Multicenter, Open-Label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Mezagitamab (TAK-079) in Patients With Primary IgA Nephropathy in Combination With Stable Background Therapy
Enrollment Status: Completed
Publish Date: June 01, 2026
Intervention Type: Drug
Study Drug: Mezagitamab
Study Phase: Phase 1
A Multi-Center, Randomized, Two-Cohort Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of CTAP101 (Calcifediol) Extended-Release Capsules to Treat Secondary Hyperparathyroidism in Subjects With Vitamin D Insufficiency and Chronic Kidney Disease Requiring Regular Hemodialysis.
A Multi-Center, Randomized, Two-Cohort Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of CTAP101 (Calcifediol) Extended-Release Capsules to Treat Secondary Hyperparathyroidism in Subjects With Vitamin D Insufficiency and Chronic Kidney Disease Requiring Regular Hemodialysis.
Enrollment Status: Terminated
Publish Date: April 03, 2026
Intervention Type: Drug
Study Drug: Calcifediol
Study Phase: Phase 2
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Enrollment Status: Completed
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
Enrollment Status: Terminated
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drug: Bardoxolone
Study Phase: Phase 3
An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients With Chronic Kidney Disease
An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients With Chronic Kidney Disease
Enrollment Status: Terminated
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drug: Bardoxolone
Study Phase: Phase 3
The Effects of 12-months of Denosumab on Bone Density, Quality and Strength in Prevalent Kidney Transplant Recipients
The Effects of 12-months of Denosumab on Bone Density, Quality and Strength in Prevalent Kidney Transplant Recipients
Enrollment Status: Terminated
Publish Date: July 25, 2024
Intervention Type: Other, Drug
Study Drug: Denosumab
Study Phase: Phase 2
A Prospective, Multicenter, Open-label, Randomized, Cross-over Study to Compare the Efficacy and Safety of Fosrenol® and Sevelamer Hydrochloride in Patients Receiving Hemodialysis for End Stage Renal Disease
A Prospective, Multicenter, Open-label, Randomized, Cross-over Study to Compare the Efficacy and Safety of Fosrenol® and Sevelamer Hydrochloride in Patients Receiving Hemodialysis for End Stage Renal Disease
Enrollment Status: Completed
Publish Date: June 11, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials

86 Total Publications

Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.
Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.
Journal: Kidney360
Published: April 17, 2026
Similar Doctors
Expertise in
14
conditions
Dr. Daniel R. Ganger
Transplant Surgery
Expertise in
14
conditions
Dr. Daniel R. Ganger
Transplant Surgery
Referral may be required
Before you request
259 E Erie St Ste 1600, Lavin Family Pavilion, 
Chicago, IL 
 (12.2 miles away)
312-695-4837
Languages Spoken:
English, Hebrew, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Ganger is a Transplant Surgeon practicing medicine in Chicago, Illinois. Dr. Ganger is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Liver Failure, Hepatitis, Cirrhosis, Liver Transplant, and Endoscopy. Dr. Ganger is board certified in American Board Of Internal Medicine - Gastroenterology (Certified). Dr. Ganger is currently accepting new patients.

Expertise in
15
conditions
Dr. Daniela P. Ladner
Transplant Surgery
Expertise in
15
conditions
Dr. Daniela P. Ladner
Transplant Surgery
Referral may be required
Before you request
676 N St Clair St 19th Fl, Arkes Pavilion, 
Chicago, IL 
 (12.2 miles away)
312-695-8900
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniela Ladner is a Transplant Surgeon practicing medicine in Chicago, Illinois. Dr. Ladner is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Liver Failure, Hepatitis, Polycystic Kidney Disease, Liver Transplant, and Kidney Transplant. Dr. Ladner is board certified in American Board Of Surgery - Surgery (Certified). Dr. Ladner is currently accepting new patients.

Expertise in
9
conditions
Dr. Piotr P. Witkowski
Transplant Surgery | General Surgery
Expertise in
9
conditions
Dr. Piotr P. Witkowski
Transplant Surgery | General Surgery
Referral may be required

UChicago Medicine Duchossois Center For Advanced Medicine - Hyde Park

5758 S. Maryland Ave., 
Chicago, IL 
 (19.4 miles away)
888-824-0200
Languages Spoken:
English, Polish, Spanish
See accepted insurances
Accepting New Patients

Piotr Witkowski is a Transplant Surgeon and a General Surgeon practicing medicine in Chicago, Illinois. Dr. Witkowski is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Chronic Pancreatitis, Hereditary Pancreatitis, Childhood Pancreatitis, Islet Cell Transplantation, and Pancreatectomy. Dr. Witkowski is currently accepting new patients.

Frequently Asked Questions about Dr. Stuart M. Sprague

How do I make an appointment with Dr. Stuart M. Sprague?

You can book an appointment with Dr. Stuart M. Sprague by calling their office at 847-570-2512. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Stuart M. Sprague a top-rated expert for Chronic Kidney Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Stuart M. Sprague is classified as an Elite expert for Chronic Kidney Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Stuart M. Sprague specialize in?

While Dr. Stuart M. Sprague is a Nephrology, they have specific expertise in Chronic Kidney Disease, Hypercalcemia, and Milk-Alkali Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Nephrology.

Does Dr. Stuart M. Sprague participate in research or clinical trials?

Yes. Dr. Stuart M. Sprague has published 86 articles and abstracts on conditions like Chronic Kidney Disease. You can view a list of Dr. Stuart M. Sprague's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Stuart M. Sprague accept my insurance?

Dr. Stuart M. Sprague accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 847-570-2512 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sprague's expertise for a condition
ConditionClose
View All 12 Distinguished Conditions
View All 23 Advanced Conditions
View All 47 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile